BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12557722)

  • 21. Experience in a UK cancer centre of weekly paclitaxel in the treatment of relapsed ovarian and primary peritoneal cancer.
    Linch M; Stavridi F; Hook J; Barbachano Y; Gore M; Kaye SB
    Gynecol Oncol; 2008 Apr; 109(1):27-32. PubMed ID: 18262259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Weekly paclitaxel therapy for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kimura F; Fukuda K; Yamamoto M; Yano T; Yamada K
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):221-6. PubMed ID: 11865627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Two cases of effective weekly paclitaxel administration for metastatic breast cancer].
    Kokufu I; Taniguchi H; Kim Y; Fukuda K; Yamamoto M; Yano T; Yamada K; Kitano H
    Gan To Kagaku Ryoho; 2001 Nov; 28(12):1905-8. PubMed ID: 11729485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weekly 1 hour paclitaxel infusion in patients with recurrent gynecological tumors: a pilot study.
    Ota S; Sugiyama T; Komai K; Hirai N; Kumagai S; Ushijima K; Nishida T; Kamura T
    Jpn J Clin Oncol; 2001 Aug; 31(8):395-8. PubMed ID: 11574633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A simplified premedication schedule for 1-hour paclitaxel administration.
    Tsavaris N; Kosmas C; Vadiaka M
    J Support Oncol; 2005; 3(1):77-81. PubMed ID: 15724950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Weekly administration of paclitaxel and pirarubicine for recurrent breast cancer].
    Shimizu T; Iwasa T; Koike S; Nakamura T; Kanai T; Komatsu D
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):105-9. PubMed ID: 12557713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I evaluation of continuous 5-fluorouracil infusion followed by weekly paclitaxel in patients with advanced or recurrent gastric cancer.
    Kondo K; Kobayashi M; Kojima H; Hirabayashi N; Kataoka M; Araki K; Matsui T; Takiyama W; Miyashita Y; Nakazato H; Nakao A; Sakamoto J
    Jpn J Clin Oncol; 2005 Jun; 35(6):332-7. PubMed ID: 15961435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The combination of monthly carboplatin and weekly paclitaxel is highly active for the treatment of recurrent ovarian cancer.
    Hoekstra AV; Hurteau JA; Kirschner CV; Rodriguez GC
    Gynecol Oncol; 2009 Dec; 115(3):377-81. PubMed ID: 19800107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of weekly administration of paclitaxel for advanced or recurrent gastric cancer with peritoneal dissemination].
    Hikino H; Yamada T; Hata T; Nakamura K; Sugimoto S; Kanazawa A; Tokuka A; Ozaki N
    Gan To Kagaku Ryoho; 2004 May; 31(5):759-61. PubMed ID: 15170988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical efficacy and safety of weekly paclitaxel therapy as second-line chemotherapy for patients with advanced and recurrent gastric cancer who were previously treated with TS-1 therapy].
    Hatori S; Kunisaki C; Ono H; Sato T; Otsuka Y; Yamada R; Ohshima T; Rino Y; Imada T
    Gan To Kagaku Ryoho; 2006 Sep; 33(9):1257-60. PubMed ID: 16969021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study of paclitaxel and estramustine in patients with recurrent and refractory non-Hodgkin lymphoma.
    Borghaei H; Millenson M; Schilder R; Alden M; Rogatko A; Wang H; Padavic-Shaller K; Smith MR
    Cancer; 2004 Nov; 101(9):2034-41. PubMed ID: 15455357
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I trial of combined-modality therapy for localized esophageal cancer: escalating doses of continuous-infusion paclitaxel with cisplatin and concurrent radiation therapy.
    Brenner B; Ilson DH; Minsky BD; Bains MS; Tong W; Gonen M; Kelsen DP
    J Clin Oncol; 2004 Jan; 22(1):45-52. PubMed ID: 14701767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Consolidation therapy with weekly paclitaxel infusion in advanced epithelial ovarian cancer and primary peritoneal cancer: an extended follow-up.
    Skinner EN; Boruta DM; Gehrig PA; Boggess JF; Fowler WC; Van Le L
    Gynecol Oncol; 2005 Jul; 98(1):59-62. PubMed ID: 15913741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma.
    Rizzieri DA; Sand GJ; McGaughey D; Moore JO; DeCastro C; Chao NJ; Vredenburgh JJ; Gasparetto C; Long GD; Anderson E; Foster T; Toaso B; Adams D; Niedzwiecki D; Gockerman JP
    Cancer; 2004 Jun; 100(11):2408-14. PubMed ID: 15160345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer].
    Kii T; Takiuchi H; Gotoh M; Kawabe S; Ohta S; Tanaka T; Kuwakado S; Nishitani H; Katsu K
    Gan To Kagaku Ryoho; 2006 May; 33(5):621-4. PubMed ID: 16685160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.
    ; Markman M; Blessing J; Rubin SC; Connor J; Hanjani P; Waggoner S
    Gynecol Oncol; 2006 Jun; 101(3):436-40. PubMed ID: 16325893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of 3-h infusion of paclitaxel in patients with adenocarcinoma of endometrium: Japanese Multicenter Study Group.
    Hirai Y; Hasumi K; Onose R; Kuramoto H; Kuzuya K; Hatae M; Ochiai K; Nozawa S; Noda K
    Gynecol Oncol; 2004 Aug; 94(2):471-6. PubMed ID: 15297190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.
    Yamamoto N; Tsurutani J; Yoshimura N; Asai G; Moriyama A; Nakagawa K; Kudoh S; Takada M; Minato Y; Fukuoka M
    Anticancer Res; 2006; 26(1B):777-81. PubMed ID: 16739353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I trial of intraperitoneal sustained-release paclitaxel microspheres (Paclimer) in recurrent ovarian cancer: a Gynecologic Oncology Group study.
    Armstrong DK; Fleming GF; Markman M; Bailey HH
    Gynecol Oncol; 2006 Nov; 103(2):391-6. PubMed ID: 16626792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter phase II trial of Genexol-PM, a Cremophor-free, polymeric micelle formulation of paclitaxel, in patients with metastatic breast cancer.
    Lee KS; Chung HC; Im SA; Park YH; Kim CS; Kim SB; Rha SY; Lee MY; Ro J
    Breast Cancer Res Treat; 2008 Mar; 108(2):241-50. PubMed ID: 17476588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.